Long-term safety and disease control with Ruxolitinib cream in atopic dermatitis: Pooled results from two phase 3 studies

被引：0
作者：
Papp, K. [1 ]
Szepietowski, J. C. [2 ]
Kircik, L. [3 ]
Toth, D. [4 ]
Eichenfield, L. F. [5 ,6 ]
Forman, S. B. [7 ]
Kuligowski, M. E. [8 ]
Venturanza, M. E. [8 ]
Ren, H. [8 ]
Simpson, E. L. [9 ]
机构：
[1] K Papp Clin Res & Prob Med Res, Waterloo, ON, Canada
[2] Wroclaw Med Univ, Dept Dermatol Venereol & Allergol, Wroclaw, Poland
[3] Icahn Sch Med Mt Sinai, New York, NY USA
[4] XLR8 Med Res & Prob Med Res, Windsor, ON, Canada
[5] Univ Calif San Diego, Dept Dermatol, San Diego, CA 92103 USA
[6] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA
[7] ForCare Clin Res, Tampa, FL USA
[8] Incyte Corp, Wilmington, NC USA
[9] Oregon Hlth & Sci Univ, Portland, OR USA
来源：
EXPERIMENTAL DERMATOLOGY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
94
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
[41]   Long-Term Safety and Disease Control of Ruxolitinib Cream in Children Aged 2 to 6 and 7 to 11 Years: Results From the TRuE-AD3 Study [J].
Soong, Weily ;
Zaenglein, Andrea ;
Tollefson, Megha ;
Simpson, Eric ;
Devani, Alim ;
Joyce, Joel ;
Schlessinger, Joel ;
Siri, Dareen ;
Angel, Brett ;
Sturm, Daniel ;
Li, Qian ;
Paller, Amy .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) :AB191-AB191
[42]   Long-term disease control in atopic dermatitis using biologics [J].
Thyssen, Jacob P. ;
Schmid-Grendelmeier, Peter .
LANCET, 2023, 401 (10372) :172-173
[43]   Pimecrolimus cream 1% provides effective long-term control of atopic dermatitis in infants [J].
Papp, K ;
Kapp, A ;
Ruer-Mulard, M ;
Davidson, MJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) :P65-P65
[44]   Long-term 4-year safety of upadacitinib in moderate-to-severe atopic dermatitis: results of an integrated analysis of phase 3 studies [J].
Silverberg, Jonathan, I ;
Bunick, Christopher G. ;
Lio, Peter ;
Guttman-Yassky, Emma ;
Boguniewicz, Mark ;
Blauvelt, Andrew ;
Bieber, Thomas ;
Thyssen, Jacob P. ;
Suravaram, Smitha ;
Khan, Nasser S. ;
Dilley, Deanne M. ;
Teixeira, Henrique D. ;
Vigna, Namita V. ;
Gamelli, Amy ;
Grada, Ayman ;
Irvine, Alan D. .
BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
[45]   Effect of ruxolitinib cream on sleep disturbance and sleep impairment: Pooled analysis from two randomized phase 3 studies [J].
Simpson, Eric L. ;
Boguniewicz, Mark ;
Thaci, Diamant ;
Misery, Laurent ;
Silverberg, Jonathan I. ;
Beck, Lisa A. ;
Kuligowski, Michael E. ;
Venturanza, May E. ;
Sun, Kang ;
Szepietowski, Jacek C. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) :AB121-AB121
[46]   PATIENT-REPORTED OUTCOMES AND FAMILY IMPACT WITH ROFLUMILAST CREAM IN ATOPIC DERMATITIS: POOLED PHASE 3 RESULTS [J].
Simpson, E. ;
Boguniewicz, M. ;
Eichenfield, L. ;
Geng, B. ;
Prajapati, V. ;
Friedlander, S. Fallon ;
Berk, D. ;
Chu, D. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) :S9-S9
[47]   Long-term safety of tacrolimus ointment in atopic dermatitis [J].
Remitz, Anita ;
Reitamo, Sakari .
EXPERT OPINION ON DRUG SAFETY, 2009, 8 (04) :501-506
[48]   Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children:: A two-year study [J].
Papp, KA ;
Werfel, T ;
Fölster-Holst, R ;
Ortonne, JP ;
Potter, PC ;
de Prost, Y ;
Davidson, MJ ;
Barbier, N ;
Goertz, HP ;
Paul, C .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (02) :240-246
[49]   Pimecrolimus cream 1% provides long-term disease management in children with severe atopic dermatitis [J].
Kaufmann, R ;
Goodfield, M ;
Kapp, A ;
Gourmala, N .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) :350-350
[50]   Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial [J].
Fuxench, Zelma C. Chiesa ;
Lai, Zhihong ;
Kuo, Yutzu ;
Nawaz, Haq ;
Cotliar, Jonathan .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2025, 36 (01)
12345